FDA
approval
· 2022-02-18
FDA Approved: NEPHROSCAN — Original Application (Theragnostics Inc)
Summary
FDA approved NEPHROSCAN (SUCCIMER) from Theragnostics Inc. through an original NDA. It is intended as a renal imaging agent to assess kidney function.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NEPHROSCAN (SUCCIMER)